glp 1 schizophrenia Glucagon-like peptide-1 medicines in neurological and psychiatric disorders: Cell Reports Medicine Frontiers | Potential role of

Timely N-acetyl-cysteine and environmental enrichment rescue oxidative stress-induced parvalbumin interneuron impairments via MMP9/RAGE pathway: a translational approach for early intervention in psychosis

PKA and Epac-2 trigger the closure of KATP and KV channels, which depolarizes the cell membrane, opens voltage-dependent calcium channels (VDCC), and causes Ca2+ influx

Intracranial and spinal melanotic schwannoma in the same patient

Naoxintong capsule alternates gut microbiota and prevents hyperlipidemia in high-fat-diet fed rats

While GLP-1 medications like semaglutide and tirzepatide have demonstrated significant weight loss effects, their specific role in lipedema management remains under investigation